Faculty Advisor

Rolle, Marsha W.

Faculty Advisor

Vassallo, Helen G.

Abstract

Cardiovascular disease is the number one leading cause of death in the United States. Myocardial infarctions are caused by cardiovascular disease and more specifically, by the blocking of a main artery in the heart. A team of students at WPI designed a device and method for producing tissue engineered blood vessels (TEBVs), which are proposed to be a new and effective treatment for coronary artery bypass surgery. The purpose of this study was to decide whether TEBVs were a worthwhile commercial venture. Currently, the method to produce the TEBVs is still being altered and the grafts are still in the early development stages. It was determined, however, that TEBVs are a worthwhile venture to invest in due to the high demand in the cardiovascular disease treatment market.

Publisher

Worcester Polytechnic Institute

Date Accepted

April 2011

Major

Management Engineering

Project Type

Major Qualifying Project

Accessibility

Unrestricted

Advisor Department

Biomedical Engineering

Advisor Department

Business

Your accessibility may vary due to other restrictions.

Share

COinS